Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Provention Bio, Inc. (PRVB)
|
Add to portfolio |
|
|
|
| Price: |
$5.91
| | Metrics |
| OS: |
81.5
|
M
| |
-133
|
% ROE
|
| Market cap: |
$482
|
M
| |
-433
|
% ROIC
|
|
Net cash:
|
$96.1
|
M
| |
$1.18
|
per share
|
|
EV:
|
$386
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($111)
|
M
| |
|
|
|
EBIT
|
($112)
|
M
| |
|
|
| EPS |
($1.64)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 |
| Revenues | 1.4 | 0.0 | 0.0 | 0.0 | 0.0 |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 1.4 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross margin | 100.0% | | | | |
| Research and development | 69.6 | 66.4 | 36.4 | 22.6 | 7.7 |
| General and administrative | 47.3 | 33.3 | 8.0 | 4.2 | 1.5 |
| EBIT | -115.6 | -99.7 | -44.4 | -26.8 | -9.1 |
| EBIT margin | -8285.2% | | | | |
| Pre-tax income | -115.4 | -99.1 | -43.3 | -26.7 | -9.1 |
| Income taxes | -1.0 | -0.5 | 0.0 | -0.2 | 0.0 |
| Tax rate | 0.9% | 0.5% | 0.0% | 0.7% | 0.0% |
| Net income | -114.4 | -98.6 | -43.3 | -26.8 | -9.5 |
| Net margin | -8203.0% | | | | |
| |
| Diluted EPS | ($1.81) | ($1.88) | ($1.06) | ($1.19) | ($1.01) |
| Shares outstanding (diluted) | 63.1 | 52.5 | 40.7 | 22.4 | 9.4 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|